Results 171 to 180 of about 3,296,751 (334)

INTERNATIONAL EXPERIENCE OF ADMINISTRATION OF PNEUMOCOCCAL CONJUGATED VACCINES: PROBLEMS, PROGRESS, PERSPECTIVES

open access: yesВопросы современной педиатрии, 2009
This article presents the review of results of International conference on pneumococcal conjugated vaccines. Main results of international experience in the field of control of pneumococcal infection spreading are analyzed. Authors present modern data of
M.V. Fedoseenko, L.S. Namazova-Baranova
doaj  

Disparities in Respiratory Syncytial Virus Vaccine Uptake in the Medicare Fee‐for‐Service Population During 2023–2024 Season

open access: yesJournal of the American Geriatrics Society, Volume 73, Issue 10, Page 3196-3202, October 2025.
ABSTRACT Background Respiratory syncytial virus (RSV) is a common cause of acute respiratory illness and can lead to serious morbidity and mortality in older adults. With the Food and Drug Administration approval and the Centers for Disease Control and Prevention (CDC) recommendation of RSV vaccines in 2023, this study describes first season vaccine ...
Austin Murphy   +7 more
wiley   +1 more source

Prevention of pneumococcal infections during mass gathering

open access: yesHuman Vaccines & Immunotherapeutics, 2016
J. Al-Tawfiq, Z. Memish
semanticscholar   +1 more source

Managing infectious aerosols to counter engineered pandemics: Current recommendations and future research

open access: yesRisk Analysis, Volume 45, Issue 10, Page 3045-3078, October 2025.
Abstract In the increasingly likely event of an engineered‐virus outbreak or pandemic of catastrophic potential, managing infectious aerosols to reduce transmission will be crucial. Now is the time to start preparing our buildings, public opinion, and regulatory environments for the infectious aerosol management interventions necessary to protect the ...
Adam Lerner   +7 more
wiley   +1 more source

The Captain of the Men of Death and His Shadow: Long-Run Impacts of Early Life Pneumonia Exposure [PDF]

open access: yes
We exploit the introduction of sulfa drugs in 1937 to identify the causal impact of exposure to pneumonia in infancy on later life well-being and productivity in the United States.
Atheendar Venkataramani, Sonia Bhalotra
core   +3 more sources

Peptidoglycan Recognition Protein 4 Limits Bacterial Clearance and Inflammation in Lungs by Control of the Gut Microbiota [PDF]

open access: yes, 2019
Aly, Sahar   +15 more
core   +1 more source

Immunization of Humans with Recombinant Pneumococcal Surface Protein A (rPspA) Elicits Antibodies That Passively Protect Mice from Fatal Infection withStreptococcus pneumoniaeBearing Heterologous PspA [PDF]

open access: bronze, 2000
David E. Briles   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy